PHIBRO ANIMAL HEALTH CORP-A (PAHC) Stock Analyst Earnings Estimates
NASDAQ:PAHC - Nasdaq - US71742Q1067 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 942.3M 13.07% | 977.9M 3.78% | 1.018B 4.07% | 1.304B 28.13% | 1.475B 13.11% | 1.52B 3.05% | 1.558B 2.50% | 1.181B -24.20% | |
| EBITDA YoY % growth | 111.71M 4.61% | 105.81M -5.28% | 110.762M 4.68% | 209.46M 89.11% | 239.58M 14.38% | 233.58M -2.50% | 244.8M 4.80% | 148.92M -39.17% | |
| EBIT YoY % growth | 79M 5.47% | 71.8M -9.11% | 74.584M 3.88% | 148.87M 99.60% | 176.22M 18.37% | 187.76M 6.55% | 204M 8.65% | 120.36M -41.00% | |
| Operating Margin | 8.38% | 7.34% | 7.33% | 11.42% | 11.95% | 12.35% | 13.09% | 10.19% | |
| EPS YoY % growth | 1.21 -4.72% | 1.22 0.83% | 1.19 -2.46% | 2.08 74.86% | 2.38 14.38% | 2.68 12.71% | 3.09 15.21% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.53 29.37% | 0.68 95.26% | 0.61 13.33% | 0.63 0.38% | 0.55 3.85% |
| Revenue Q2Q % growth | 369.48M 35.24% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 59.038M -1.98% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 39.872M 65.79% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.63 103.23% | 0.53 | 0.10 | 18.78% |
| Q2 2025 Q2Q % growth | 0.54 63.64% | 0.43 | 0.11 | 24.57% |
| Q1 2025 Q2Q % growth | 0.35 150.00% | 0.25 | 0.10 | 38.92% |
| Q4 2024 Q2Q % growth | 0.41 7.89% | 0.34 | 0.07 | 20.59% |
| Q3 2024 Q2Q % growth | 0.31 6.90% | 0.30 | 0.01 | 4.80% |
| Q2 2024 Q2Q % growth | 0.33 -2.94% | 0.29 | 0.04 | 15.65% |
| Q1 2024 Q2Q % growth | 0.14 -33.33% | 0.23 | -0.09 | -40.32% |
| Q4 2023 Q2Q % growth | 0.38 46.15% | 0.39 | -0.01 | -3.05% |
| Q3 2023 Q2Q % growth | 0.29 -12.12% | 0.34 | -0.05 | -15.13% |
| Q2 2023 Q2Q % growth | 0.34 -8.11% | 0.31 | 0.03 | 10.01% |
| Q1 2023 Q2Q % growth | 0.21 -16.00% | 0.27 | -0.06 | -22.41% |
| Q4 2022 Q2Q % growth | 0.26 -18.75% | 0.39 | -0.13 | -33.39% |
| Q3 2022 Q2Q % growth | 0.33 -2.94% | 0.36 | -0.03 | -8.43% |
| Q2 2022 Q2Q % growth | 0.37 8.82% | 0.33 | 0.04 | 11.04% |
| Q1 2022 Q2Q % growth | 0.25 -7.41% | 0.30 | -0.05 | -16.44% |
| Q4 2021 Q2Q % growth | 0.32 88.24% | 0.32 | 0.00 | 0.47% |
| Q3 2021 Q2Q % growth | 0.34 -10.53% | 0.34 | 0.00 | -0.68% |
| Q2 2021 Q2Q % growth | 0.34 | 0.27 | 0.07 | 24.84% |
| Q1 2021 Q2Q % growth | 0.27 42.11% | 0.24 | 0.03 | 13.51% |
| Q4 2020 Q2Q % growth | 0.17 -48.48% | 0.22 | -0.05 | -24.04% |
| Q3 2020 Q2Q % growth | 0.38 -2.56% | 0.35 | 0.03 | 9.64% |
| Q2 2020 Q2Q % growth | 0.34 -17.07% | 0.29 | 0.05 | 16.80% |
| Q1 2020 Q2Q % growth | 0.19 -51.28% | 0.25 | -0.06 | -22.77% |
| Q4 2019 Q2Q % growth | 0.33 | 0.37 | -0.04 | -10.43% |
| Q3 2019 Q2Q % growth | 0.39 | 0.44 | -0.05 | -11.29% |
| Q2 2019 Q2Q % growth | 0.41 | 0.44 | -0.03 | -6.74% |
| Q1 2019 Q2Q % growth | 0.39 | 0.42 | -0.03 | -6.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 347.8M 32.14% | 359.45M | -11.65M | -3.24% |
| Q2 2025 Q2Q % growth | 309.3M 23.77% | 309.92M | -620K | -0.20% |
| Q1 2025 Q2Q % growth | 260.4M 12.56% | 249.29M | 11.11M | 4.46% |
| Q4 2024 Q2Q % growth | 273.2M 7.14% | 268.51M | 4.69M | 1.75% |
| Q3 2024 Q2Q % growth | 263.2M 7.12% | 259.92M | 3.28M | 1.26% |
| Q2 2024 Q2Q % growth | 249.9M 2.17% | 247.14M | 2.76M | 1.12% |
| Q1 2024 Q2Q % growth | 231.349M -0.50% | 246.88M | -15.531M | -6.29% |
| Q4 2023 Q2Q % growth | 255M -0.12% | 261.25M | -6.25M | -2.39% |
| Q3 2023 Q2Q % growth | 245.7M 2.55% | 252.41M | -6.71M | -2.66% |
| Q2 2023 Q2Q % growth | 244.6M 5.11% | 246.11M | -1.51M | -0.61% |
| Q1 2023 Q2Q % growth | 232.5M 8.29% | 232.1M | 400K | 0.17% |
| Q4 2022 Q2Q % growth | 255.3M 15.89% | 250.94M | 4.36M | 1.74% |
| Q3 2022 Q2Q % growth | 239.6M 13.18% | 230.79M | 8.81M | 3.82% |
| Q2 2022 Q2Q % growth | 232.7M 12.91% | 221.48M | 11.22M | 5.07% |
| Q1 2022 Q2Q % growth | 214.7M 9.99% | 205.74M | 8.96M | 4.36% |
| Q4 2021 Q2Q % growth | 220.3M 18.50% | 217.73M | 2.57M | 1.18% |
| Q3 2021 Q2Q % growth | 211.7M 0.47% | 212.21M | -510K | -0.24% |
| Q2 2021 Q2Q % growth | 206.1M -3.69% | 210.49M | -4.39M | -2.09% |
| Q1 2021 Q2Q % growth | 195.2M 2.90% | 192.86M | 2.34M | 1.21% |
| Q4 2020 Q2Q % growth | 185.9M -8.83% | 192.68M | -6.78M | -3.52% |
| Q3 2020 Q2Q % growth | 210.7M 2.43% | 212.43M | -1.73M | -0.81% |
| Q2 2020 Q2Q % growth | 214M -1.92% | 223.26M | -9.26M | -4.15% |
| Q1 2020 Q2Q % growth | 189.7M -5.24% | 203.66M | -13.96M | -6.85% |
| Q4 2019 Q2Q % growth | 203.9M | 210.12M | -6.22M | -2.96% |
| Q3 2019 Q2Q % growth | 205.7M | 219.24M | -13.54M | -6.18% |
| Q2 2019 Q2Q % growth | 218.2M | 215.69M | 2.51M | 1.16% |
| Q1 2019 Q2Q % growth | 200.2M | 208.2M | -8M | -3.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.11% | -0.49% | 5.15% |
| Revenue | 0% | 0.28% | -0.15% | 0.23% |